EVA1A and cancer: TMEM166 overexpression inhibits multiple human cancer cell growth in vitro and in vivo via autophagy and apoptosis [17–20], whereas miR‐103a‐3p-mediated TMEM166 knockdown promotes HCC cell proliferation and migration [21].